We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In March this year, the US Court of Appeals was ordered by the US Supreme Court to reconsider its decision in Association for Molecular Pathology v Myriad Genetics
On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram
In a decision that’s sure to find its way to the Supreme Court, the US Court of Appeals for the Federal Circuit has ruled that isolated genetic sequences are patentable
Australian biotech company Genetic Technologies (GTG) has announced that it has launched a third round of litigation against US biotech and life sciences companies it says are infringing its patented non-coding DNA technology
Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year
